Benefits, Barriers and Determinants of Clinical Pathway Use in Germany, Austria and Switzerland. A pilot study
Health Services Management Research · 2023-05 · 36 (2) · 119-126
DOI: 10.1177/09514848221107485 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Services Management Research, online erschienen am 30.06.2022. Verfasst von Elisabeth Noehammer und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department for Public Health, Health Services Research and HTA, UMIT - Private University for Health Sciences, Medical Informatics and Technology, Au…. Hauptthemen laut MEDLINE: Critical Pathways. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Tiroler Wissenschaftsfonds.
Abstract (Originalsprache)
Background
Performance-oriented financing of healthcare aims at demand-based and efficient resource allocation. Often, clinical pathways (CPs) are introduced in this context.
Purpose
For CP success (a) the degree of utilization of and divergence, (b) cost effects and (c) health professionals’ acceptance rate of and satisfaction are relevant. There are gaps in research regarding these issues in general, and more specifically in the German speaking part of Europe. Methodology/Approach Employing a two-stage mixed-methods pilot study, we studied (a) and (b) quantitatively in Germany, Austria, and Switzerland, and (c) qualitatively in Germany and Austria.
Results
Many hospitals already implemented CPs, but the utilization varies. They are expected to yield middle-range savings, but intangible benefits are more important. In general, employees are in favor of CPs, but several conditions need to be met, e.g. adaptability to local requirements.
Conclusion
Linking the results to the Consolidated Framework for Implementation Research showed many criteria are covered, which might lead to the positive evaluations, but also highlights the complexity of the intervention. Practice Implication As enhanced acceptance rates are expected to lead to higher benefits and vice versa, management team should safeguard employee participation and perceived benefits in all phases of the CP cycle.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department for Public Health, Health Services Research and HTA, UMIT - Private University for Health Sciences, Medical Informatics and Technology, Austria.
ORCID-Profile: Elisabeth Noehammer
Förderung
- Tiroler Wissenschaftsfonds
Zitieren
APA
Noehammer, E., Ponweiser, M., Romeyke, T., & Eibinger, F. (2023). Benefits, Barriers and Determinants of Clinical Pathway Use in Germany, Austria and Switzerland. A pilot study. Health Services Management Research, 36(2), 119-126. https://doi.org/10.1177/09514848221107485
Vancouver
Noehammer E, Ponweiser M, Romeyke T, Eibinger F. Benefits, Barriers and Determinants of Clinical Pathway Use in Germany, Austria and Switzerland. A pilot study. Health Services Management Research. 2023;36(2):119-126. doi:10.1177/09514848221107485
BibTeX
@article{Noehammer2023,
author = {Noehammer, Elisabeth and Ponweiser, Matthias and Romeyke, Tobias and Eibinger, Florian},
title = {Benefits, Barriers and Determinants of Clinical Pathway Use in Germany, Austria and Switzerland. A pilot study},
journal = {Health Services Management Research},
year = {2023},
volume = {36},
number = {2},
pages = {119--126},
doi = {10.1177/09514848221107485}
}
EUVIMED